Skip to main content

Table 2 90Y Resin microsphere dosimetry

From: Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases

Parameters

Median (range)

Administered activity, mCi

 

 Right lobe

38.9 (27.8–72.3)

 Left lobe

23.3 (13.1–43.3)

 Total

66.3 (34.3–115.6)

Liver volume, ml

 

 Right lobe

1151 (662–2760)

 Left lobe

584 (265–900)

Absorbed liver dose, Gy*

 

 Right lobe

65.6 (21.5–98.5)

 Left lobe

87.6 (24.8–140.1)

Lung shunt fraction, %

5.2 (1.4–17.8)

Absorbed lung dose, Gy*

4.9 (1.6–27.5)

  1. *MIRD model calculations